Scaling the Circular Bioeconomy: Unlocking Biobased Industries
A new white paper outlines the five key barriers and five promising solutions for scaling biobased industries.
The circular bioeconomy presents one of the greatest business opportunities of the 21st century. It represents a systemic alternative to the current extractive, linear, fossil-based economy and offers holistic solutions to pollution, climate change and biodiversity loss as well as to resource security and economic prosperity.
Biobased industries play a crucial role in this transition: these are technologies and sectors that harness biological resources and processes to replace fossil-based products across chemicals, materials, packaging, textiles and agricultural inputs. Against a backdrop of rising climate-related losses and growing geopolitical risk, scaling these industries is imperative, but faces structural barriers.
Through the CBA’s multi-stakeholder engagement, we have identified the following critical bottlenecks:
- The fossil price gap and commercialisation valley of death
- The finance gap and patient capital deficit
- Weak and inconsistent demand signals
- Infrastructure and value-chain fragmentation
- Policy fragmentation and regulatory uncertainty
Five promising steps we can take to accelerate progress include:
- Creating demand certainty
- Deploying patient, blended capital
- Pricing in externalities and strengthening policy
- Supporting fast, low-cost pilots and corporate validation: the Living Labs model
- Deepening collaboration and building a stronger narrative
To do so will require closer alignment between innovators, corporates and financiers. The Circular Bioeconomy Alliance (CBA) will continue to convene key partners to drive action forward and bring the bioeconomy from niche to norm.
The white paper is informed by the Roundtable on Scaling the Circular Bioeconomy, which was convened by the Circular Bioeconomy Alliance (CBA) and hosted at Windsor Castle on 30 March 2026, followed by a reception with His Majesty King Charles III. The roundtable brought together investors, corporations, and solution-providers to focus on accelerating the transition to a biobased economy.
Image: Adobe Stock / kwanchaift
